FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2337803838> ?p ?o ?g. }

• W2337803838 abstract "Bevacizumab, a monoclonal antibody against vascular endothelial growth factor ligand, has shown survival benefits in the treatment of many types of malignant tumors, including non-small-cell lung cancer (NSCLC). We conducted this systematic review and meta-analysis to investigate the risk of the most clinically relevant adverse events related to bevacizumab in advanced NSCLC.Databases from PubMed, Web of Science, and Cochrane Library up to August 2015, were searched to identify relevant studies. We included prospective randomized controlled Phase II/III clinical trials that compared therapy with or without bevacizumab for advanced NSCLC. Summary relative risk (RR) and 95% confidence intervals were calculated using random effects or fixed effects according to the heterogeneity among included trials.A total of 3,745 patients from nine clinical trials were included in the meta-analysis. Summary RRs showed a statistically significant bevacizumab-associated increased risk in three of the adverse outcomes studied: proteinuria (RR =7.55), hypertension (RR =5.34), and hemorrhagic events (RR =2.61). No statistically significant differences were found for gastrointestinal perforation (P=0.60), arterial and venous thromboembolic events (P=0.35 and P=0.92, respectively), or fatal events (P=0.29).The addition of bevacizumab to therapy in advanced NSCLC did significantly increase the risk of proteinuria, hypertension, and hemorrhagic events but not arterial/venous thromboembolic events, gastrointestinal perforation, or fatal adverse events." @default.
• W2337803838 created "2016-06-24" @default.
• W2337803838 creator A5002627636 @default.
• W2337803838 creator A5014919851 @default.
• W2337803838 creator A5027351735 @default.
• W2337803838 creator A5075950886 @default.
• W2337803838 date "2016-04-01" @default.
• W2337803838 modified "2023-10-16" @default.
• W2337803838 title "Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials" @default.
• W2337803838 cites W1970253348 @default.
• W2337803838 cites W1977379029 @default.
• W2337803838 cites W1978139448 @default.
• W2337803838 cites W1998462298 @default.
• W2337803838 cites W2000442546 @default.
• W2337803838 cites W2003417814 @default.
• W2337803838 cites W2012852444 @default.
• W2337803838 cites W2013865180 @default.
• W2337803838 cites W2026528263 @default.
• W2337803838 cites W2040253672 @default.
• W2337803838 cites W2046507292 @default.
• W2337803838 cites W2048818094 @default.
• W2337803838 cites W2054979979 @default.
• W2337803838 cites W2057550630 @default.
• W2337803838 cites W2060251426 @default.
• W2337803838 cites W2063490878 @default.
• W2337803838 cites W2086619383 @default.
• W2337803838 cites W2096134439 @default.
• W2337803838 cites W2100327051 @default.
• W2337803838 cites W2100669312 @default.
• W2337803838 cites W2100756525 @default.
• W2337803838 cites W2100785570 @default.
• W2337803838 cites W2102967512 @default.
• W2337803838 cites W2104569020 @default.
• W2337803838 cites W2108923852 @default.
• W2337803838 cites W2111053501 @default.
• W2337803838 cites W2112759697 @default.
• W2337803838 cites W2113122060 @default.
• W2337803838 cites W2121785313 @default.
• W2337803838 cites W2123629654 @default.
• W2337803838 cites W2125435699 @default.
• W2337803838 cites W2135140316 @default.
• W2337803838 cites W2135947389 @default.
• W2337803838 cites W2136601558 @default.
• W2337803838 cites W2144660856 @default.
• W2337803838 cites W2145835533 @default.
• W2337803838 cites W2155338842 @default.
• W2337803838 cites W2157823046 @default.
• W2337803838 cites W2161701454 @default.
• W2337803838 cites W2166573361 @default.
• W2337803838 cites W4250428608 @default.
• W2337803838 doi "https://doi.org/10.2147/ott.s96156" @default.
• W2337803838 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4844428" @default.
• W2337803838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27143937" @default.
• W2337803838 hasPublicationYear "2016" @default.
• W2337803838 type Work @default.
• W2337803838 sameAs 2337803838 @default.
• W2337803838 citedByCount "9" @default.
• W2337803838 countsByYear W23378038382017 @default.
• W2337803838 countsByYear W23378038382018 @default.
• W2337803838 countsByYear W23378038382020 @default.
• W2337803838 countsByYear W23378038382021 @default.
• W2337803838 crossrefType "journal-article" @default.
• W2337803838 hasAuthorship W2337803838A5002627636 @default.
• W2337803838 hasAuthorship W2337803838A5014919851 @default.
• W2337803838 hasAuthorship W2337803838A5027351735 @default.
• W2337803838 hasAuthorship W2337803838A5075950886 @default.
• W2337803838 hasBestOaLocation W23378038381 @default.
• W2337803838 hasConcept C126322002 @default.
• W2337803838 hasConcept C141071460 @default.
• W2337803838 hasConcept C143998085 @default.
• W2337803838 hasConcept C168563851 @default.
• W2337803838 hasConcept C191897082 @default.
• W2337803838 hasConcept C192562407 @default.
• W2337803838 hasConcept C197934379 @default.
• W2337803838 hasConcept C2776256026 @default.
• W2337803838 hasConcept C2776478404 @default.
• W2337803838 hasConcept C2776694085 @default.
• W2337803838 hasConcept C2777802072 @default.
• W2337803838 hasConcept C2778456384 @default.
• W2337803838 hasConcept C2778527123 @default.
• W2337803838 hasConcept C2779561371 @default.
• W2337803838 hasConcept C2780091579 @default.
• W2337803838 hasConcept C2780199535 @default.
• W2337803838 hasConcept C2780356529 @default.
• W2337803838 hasConcept C44249647 @default.
• W2337803838 hasConcept C71924100 @default.
• W2337803838 hasConcept C82789193 @default.
• W2337803838 hasConcept C95190672 @default.
• W2337803838 hasConceptScore W2337803838C126322002 @default.
• W2337803838 hasConceptScore W2337803838C141071460 @default.
• W2337803838 hasConceptScore W2337803838C143998085 @default.
• W2337803838 hasConceptScore W2337803838C168563851 @default.
• W2337803838 hasConceptScore W2337803838C191897082 @default.
• W2337803838 hasConceptScore W2337803838C192562407 @default.
• W2337803838 hasConceptScore W2337803838C197934379 @default.
• W2337803838 hasConceptScore W2337803838C2776256026 @default.
• W2337803838 hasConceptScore W2337803838C2776478404 @default.
• W2337803838 hasConceptScore W2337803838C2776694085 @default.
• W2337803838 hasConceptScore W2337803838C2777802072 @default.
• W2337803838 hasConceptScore W2337803838C2778456384 @default.

• next